209 related articles for article (PubMed ID: 30645688)
1. Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.
Barnes BJ
Curr Rheumatol Rep; 2019 Jan; 21(1):2. PubMed ID: 30645688
[TBL] [Abstract][Full Text] [Related]
2. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
3. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
[TBL] [Abstract][Full Text] [Related]
4. The
Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
[TBL] [Abstract][Full Text] [Related]
5. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
[TBL] [Abstract][Full Text] [Related]
6. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.
Alonso-Perez E; Suarez-Gestal M; Calaza M; Kwan T; Majewski J; Gomez-Reino JJ; Gonzalez A
Arthritis Res Ther; 2011 May; 13(3):R80. PubMed ID: 21627826
[TBL] [Abstract][Full Text] [Related]
7. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
10. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
Cham CM; Ko K; Niewold TB
Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
[TBL] [Abstract][Full Text] [Related]
12. Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function.
Wen F; Ellingson SM; Kyogoku C; Peterson EJ; Gaffney PM
Autoimmunity; 2011 Mar; 44(2):82-9. PubMed ID: 20695768
[TBL] [Abstract][Full Text] [Related]
13. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
14. IRF5-mediated signaling and implications for SLE.
Lazzari E; Jefferies CA
Clin Immunol; 2014 Aug; 153(2):343-52. PubMed ID: 24928322
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
17. RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.
Stone RC; Du P; Feng D; Dhawan K; Rönnblom L; Eloranta ML; Donnelly R; Barnes BJ
PLoS One; 2013; 8(1):e54487. PubMed ID: 23349905
[TBL] [Abstract][Full Text] [Related]
18. Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus.
Hou G; Zhou T; Xu N; Yin Z; Zhu X; Zhang Y; Cui Y; Ma J; Tang Y; Cheng Z; Shen Y; Chen Y; Zou LH; Wang YF; Yin Z; Guo Y; Ding H; Ye Z; Shen N
Arthritis Rheumatol; 2023 Apr; 75(4):574-585. PubMed ID: 36245280
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
[TBL] [Abstract][Full Text] [Related]
20. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
